Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT05437653
Other study ID # 19047
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date March 28, 2022
Est. completion date December 30, 2023

Study information

Verified date June 2022
Source University of Nottingham
Contact Sally Eldeghaidy, PhD
Phone 0115 84 66003
Email sally.eldeghaidy@nottingham.ac.uk
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The mechanism of neural communication between the brain and gut in the regulation of food intake is complex and not fully understood. Magnetic Resonance Imaging (MRI) is a powerful non-invasive imaging tool that allows studying the function of the brain and gut. The aim of this study is to develop MRI methods to combine brain and gut imaging in a single MRI scan session. The developed techniques will then be used to assess the brain-gut axis to a high fat drink compared with iso-caloric/iso-viscous/iso-volumetric carbohydrate drink in people with obesity and healthy weight participants. The findings could provide a possible explanation for why some people are heavier than others.


Description:

20 healthy weight participant (18 Kg/m2>BMI<30Kg/m2) and 20 age- and sex- matched peoples with obesity (BMI >30 Kg/m2) will be invited to a double-blinded two-way crossover MRI study, approximately 1 week apart, to assess the interplay between brain and gut to food intake. Brain and gut MRI scans will be collected at fasted/baseline and at different time points postprandial for 120 mins using the 3T Ingenia Philips scanner. Brain measurements including resting state-fMRI, cerebral blood flow (CBF), and task-fMRI scans will be collected. During the task fMRI scan, images of high and low energy food pictures, and non-food control pictures will be presented. Food images are extensively used in fMRI studies to characterise the neural systems involved in processing the hedonic value of food as well as satiety and hunger signals. In addition to brain scans, sequences of gut scans will be collected to assess gastric volume, small bowel water content, and superior mesenteric artery (SMA) responses pre- and post-prandial. Blood samples will be collected to assess gut hormones (CCK, GLP1- PYY, ghrelin) insulin and glucose, triglycerides, free fatty acid levels at different timepoints. In addition, satiety and appetite scores will be collected using visual analogue scales. The total scan time including the fed and break times is around 3 hours.


Recruitment information / eligibility

Status Recruiting
Enrollment 40
Est. completion date December 30, 2023
Est. primary completion date April 1, 2023
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 45 Years
Eligibility Inclusion Criteria: - Aged 18-45, male and female (females will have the study days arranged during the early phase of the menstrual cycle). - Body mass index (BMI): normal weight participants = 19 and = 25 Kg/m2, and obese participants > 30 Kg/m2 - Able to give voluntary written informed consent to participate in the study - Able to understand the requirements of the study - Apparently healthy: no medical conditions which might affect study measurements (judged by health questionnaire, and blood screening) Exclusion Criteria: - Any reported history of neurological or gastrointestinal disorders - Any reported history of surgery that could affect gastrointestinal function (e.g. colectomy, small bowel resection) - Abnormal screening procedures including depression and eat restriction - Laboratory results that are clinically significant, including diabetes, dyslipidemia, pancreatitis, or untreated hypertension. - Contraindications for MRI scanning i.e. metallic implants, pacemakers, history of metallic foreign body in eye(s) and penetrating eye injury, assessed by standard MRI safety questionnaire. - Under medication (expect aspirin/paracetamol), antibiotic or prescribed probiotic treatment in the past 12 weeks. - Following a medically- or self-prescribed diet during the two weeks prior to the pre-study examination and until the end of the study. - Reported weight loss or gain = 10 % of bodyweight during the six months period before the pre-study examination - Pregnancy or breastfeeding declared by candidate - Smoking - Left-handed assessed by handedness questionnaire. This is to control for brain's lateralisation effects (activation in one side of the brain) that may show variations between left and right handed participants. - Participation in another clinical or research study within the previous 3 months of the study - Cannot lie flat or exceeding the scanner bed weight limit of 250 kg. - Poor understanding of the spoken and/or written English language

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Nutritional Drink A
300 mL of a 22% high fat emulsion (Rapeseed oil, water, emulsifier)
Nutritional Drink B
300 mL of isocaloric, iso-volumetric and iso-viscous carbohydrate drink (maltodextrin)

Locations

Country Name City State
United Kingdom University of Nottingham Nottingham

Sponsors (1)

Lead Sponsor Collaborator
University of Nottingham

Country where clinical trial is conducted

United Kingdom, 

Outcome

Type Measure Description Time frame Safety issue
Primary Changes in appetite- and satiety-related brain responses between drinks ( Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS obese) Blood oxygen level-dependent (BOLD) responses to high-calorie, low-calorie and non-food images From baseline to up to 2 hours after ingesting the drinks
Primary Changes in Cerebral blood flow between drinks (Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS Obese) Cerebral blood flow differences From baseline to up to 2 hours after ingesting the drinks
Primary Changes resting state brain networks between drinks (Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS Obese) Alterations in functional brain connectivity/networks in brain regions involved in homeostatic and hedonic brain circuits. From baseline to up to 2 hours after ingesting the drinks
Primary Changes in gastric volume between drinks (Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS Obese) Area Under the Curve of post-prandial gastric volumes, measured by MRI From baseline to up to 2 hours after ingesting the drinks
Primary Correlations between gut and brain responses to assess alterations in brain-gut axis between drinks (Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS Obese) Exploratory correlations between brain and gut responses From baseline to up to 2 hours after ingesting the drinks
Secondary Changes in small bowel water content between drinks (Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS Obese) Area Under the Curve of post-prandial small bowel water content, measured by MRI, up to 2h (AUC2h) postprandially From baseline to up to 2 hours after ingesting the drinks
Secondary Changes in satiety and appetite regulators between drinks (Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS Obese) Area Under the Curve of post-prandial serum gut hormone (CCK, GLP-1, PYY, Ghrelin), insulin, free fatty acid, glucose, and triglyceride concentrations From baseline to up to 2 hours after ingesting the drinks
Secondary Changes in satiety and appetite score (VAS) between drinks (Fat drink VS Carbohydrate drink) and across groups (Healthy weight VS Obese) Area Under the Curve for appetite (Fullness, Hunger, Prospective food consumption) post prandial 100 mm VAS scores AUC2h From baseline to up to 2 hours after ingesting the drinks
Secondary Correlations between blood, brain and gut and satiety date Exploratory correlations between blood, brain and gut responses and satiety data From baseline to up to 2 hours after ingesting the drinks
See also
  Status Clinical Trial Phase
Recruiting NCT04101669 - EndoBarrier System Pivotal Trial(Rev E v2) N/A
Recruiting NCT04243317 - Feasibility of a Sleep Improvement Intervention for Weight Loss and Its Maintenance in Sleep Impaired Obese Adults N/A
Terminated NCT03772886 - Reducing Cesarean Delivery Rate in Obese Patients Using the Peanut Ball N/A
Completed NCT03640442 - Modified Ramped Position for Intubation of Obese Females. N/A
Completed NCT04506996 - Monday-Focused Tailored Rapid Interactive Mobile Messaging for Weight Management 2 N/A
Recruiting NCT06019832 - Analysis of Stem and Non-Stem Tibial Component N/A
Active, not recruiting NCT05891834 - Study of INV-202 in Patients With Obesity and Metabolic Syndrome Phase 2
Active, not recruiting NCT05275959 - Beijing (Peking)---Myopia and Obesity Comorbidity Intervention (BMOCI) N/A
Recruiting NCT04575194 - Study of the Cardiometabolic Effects of Obesity Pharmacotherapy Phase 4
Completed NCT04513769 - Nutritious Eating With Soul at Rare Variety Cafe N/A
Withdrawn NCT03042897 - Exercise and Diet Intervention in Promoting Weight Loss in Obese Patients With Stage I Endometrial Cancer N/A
Completed NCT03644524 - Heat Therapy and Cardiometabolic Health in Obese Women N/A
Recruiting NCT05917873 - Metabolic Effects of Four-week Lactate-ketone Ester Supplementation N/A
Active, not recruiting NCT04353258 - Research Intervention to Support Healthy Eating and Exercise N/A
Completed NCT04507867 - Effect of a NSS to Reduce Complications in Patients With Covid-19 and Comorbidities in Stage III N/A
Recruiting NCT03227575 - Effects of Brisk Walking and Regular Intensity Exercise Interventions on Glycemic Control N/A
Completed NCT01870947 - Assisted Exercise in Obese Endometrial Cancer Patients N/A
Recruiting NCT05972564 - The Effect of SGLT2 Inhibition on Adipose Inflammation and Endothelial Function Phase 1/Phase 2
Recruiting NCT06007404 - Understanding Metabolism and Inflammation Risks for Diabetes in Adolescents
Recruiting NCT05371496 - Cardiac and Metabolic Effects of Semaglutide in Heart Failure With Preserved Ejection Fraction Phase 2